COVID-19, Cannabis Workers and a Request to the Vaccine Advisory Committee
Public Comment – 1b Vaccine Group Hello Mr. Dunn and Members of the Vaccine Advisory Committee: On behalf of Gleam Law, PLLC and the wonderful
Public Comment – 1b Vaccine Group Hello Mr. Dunn and Members of the Vaccine Advisory Committee: On behalf of Gleam Law, PLLC and the wonderful
TCPA and CEMA are Landmines for Marijuana Companies It seems like a no brainer. A company is offering you increased sales by virtue of a
Neil Juneja, Founding Partner of Gleam Law, speaks with Laurence Colletti of Legal Talk Network about issues surrounding patents in the cannabis industry. Listen to the
According to a recent 2021 Cannabis Jobs Report published by Leafly and Whitney Economics, jobs in the legalized cannabis industry doubled in 2020 over 2019
Are the New FDA Warning Letters Signaling Treatment of Hemp Extracts as Over the Counter Monographs? The FDA issued two new warning letters on March
Lessons learned from a Michigan Credit Union NCUA’s Cease-and-Desist Order for a Cannabis Banking Program by Alan Hanson Most people who are involved in or
Psychedelic and Cannabis Research Summit: Intellectual Property Panel Gleam Law Partners recently participated on a panel as part of the Psychedelic and Cannabis Research Summit
Is your spouse considered a True Party of Interest under Washington cannabis law? Written by Neil Juneja, Founder & Managing Partner at Gleam Law PLLC. It
Written by Orion Inskip, Attorney at Gleam Law, PLLC. Cannabis laws are rapidly evolving across the world. This has been no less true when it
BREAKING: FDA Approves CBD-Based Medicine Derived from Marijuana Written by Orion Inskip, Attorney at Gleam Law, PLLC. The Food and Drug Administration (FDA) has approved
Will Canadians Receive Lifetime Bans From The U.S. For Legal Cannabis Use? Written by Neil Juneja, Founder & Managing Partner at Gleam Law, PLLC. Canadians
California Department of Public Health Prohibits CBD in Food Products By Orion Inskip, Attorney at Gleam Law PLLC According to a recent FAQ released by
